We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Newly published research in Molecular & Cellular Proteomics* describes a biomarker panel based on patient IgM antibodies that can differentiate between Zika and Dengue virus infection for a prolonged period after initial exposure.